STAT+: Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders

STAT+: Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders

Watchdoq February 21, 2025
The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for compounding pharmacies to make copies of Ozempic and Wegovy.

Read Full Article